BioRestorative Therapies, Inc. (BRTX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $1.51M | +175.8% |
| 2024 | $547.9K | -38.0% |
| 2023 | $884.4K | -48.4% |
| 2022 | $1.71M | -91.8% |
| 2021 | $21.03M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $1.51M | +175.8% |
| 2024 | $547.9K | -38.0% |
| 2023 | $884.4K | -48.4% |
| 2022 | $1.71M | -91.8% |
| 2021 | $21.03M | — |